NicOx
| Company type | Société Anonyme |
|---|---|
| Euronext: COX Euronext Growth | |
| Industry | research and development in biotechnology |
| Founded | 1996 |
| Headquarters | , |
| Website | www |
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris (Compartment B: Mid-Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration (FDA) approved products.